BOOSTRIX suspension for injection in pre-filled syringe GLAXO SMITH KLINE ORIGINAL MEDICINE
Chemical substance: diphtheria, tetanus, pertussis vaccine
ATC code: J07AJ52 • Antiinfectives for systemic use | Bacterial vaccines | Pertussis vaccines
Active substance
Results for the substance diphtheria, tetanus, pertussis vaccine
1 result
About this active substance
The diphtheria, tetanus, pertussis (DTP) vaccine is used to prevent diphtheria, tetanus, and whooping cough, three serious infectious diseases caused by bacteria. The vaccine contains diphtheria and tetanus toxoids, as well as inactivated or purified components of Bordetella pertussis, which stimulate the immune system to produce specific antibodies against these pathogens.
The vaccine is administered intramuscularly, usually in multiple doses, according to recommended vaccination schedules for infants, children, and adolescents. Booster doses are required at regular intervals to maintain immunity.
Common side effects include pain at the injection site, mild fever, fatigue, and irritability. In rare cases, severe allergic reactions may occur.
The DTP vaccine is an essential measure for protecting public health, helping to reduce the incidence and severity of these infectious diseases and prevent the severe complications associated with them.
The vaccine is administered intramuscularly, usually in multiple doses, according to recommended vaccination schedules for infants, children, and adolescents. Booster doses are required at regular intervals to maintain immunity.
Common side effects include pain at the injection site, mild fever, fatigue, and irritability. In rare cases, severe allergic reactions may occur.
The DTP vaccine is an essential measure for protecting public health, helping to reduce the incidence and severity of these infectious diseases and prevent the severe complications associated with them.